We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Penumbra
PEN
$12.9B
| $263K | ﹤0.01% |
943
| – | – |
|
1052
PNC Financial Services
PNC
$102B
| $261K | ﹤0.01% |
2,057
-87,013
| -98% | -$13.1M |
|
|
CMBM
1053
DELISTED
Cambium Networks
CMBM
| $260K | ﹤0.01% |
14,700
+2,040
| +16% | +$41.5K |
|
1054
Ford
F
$55.3B
| $260K | ﹤0.01% |
20,661
| – | – |
|
1055
iRhythm Holdings
IRTC
$4.12B
| $260K | ﹤0.01% |
2,093
-211
| -9% | -$22.9K |
|
1056
Booz Allen Hamilton
BAH
$9.31B
| $259K | ﹤0.01% |
2,795
-13,644
| -83% | -$1.29M |
|
1057
Arrow Financial
AROW
$730M
| $259K | ﹤0.01% |
10,702
| – | – |
|
|
RDFN
1058
DELISTED
Redfin
RDFN
| $259K | ﹤0.01% |
28,561
+17,031
| +148% | +$127K |
|
1059
CVB Financial
CVBF
$4.07B
| $258K | ﹤0.01% |
15,495
-19,454
| -56% | -$443K |
|
1060
Amneal Pharmaceuticals
AMRX
$6.2B
| $258K | ﹤0.01% |
185,796
-7,049
| -4% | -$14K |
|
1061
Flex
FLEX
$46.6B
| $257K | ﹤0.01% |
+14,825
| New | +$256K |
|
1062
Ovintiv
OVV
$17.2B
| $256K | ﹤0.01% |
7,090
-182,980
| -96% | -$8.07M |
|
1063
Darling Ingredients
DAR
$10.2B
| $255K | ﹤0.01% |
4,372
-169,394
| -97% | -$10.6M |
|
1064
Flowserve
FLS
$10.1B
| $254K | ﹤0.01% |
+7,471
| New | +$250K |
|
|
MRSN
1065
DELISTED
Mersana Therapeutics
MRSN
| $254K | ﹤0.01% |
2,472
+429
| +21% | +$60.2K |
|
1066
Asbury Automotive
ABG
$3.75B
| $253K | ﹤0.01% |
1,205
-620
| -34% | -$131K |
|
1067
McKesson
MCK
$101B
| $253K | ﹤0.01% |
710
-61
| -8% | -$22K |
|
1068
Coca-Cola Europacific Partners
CCEP
$47.4B
| $252K | ﹤0.01% |
4,250
-32,359
| -88% | -$1.81M |
|
1069
Option Care Health
OPCH
$3.62B
| $250K | ﹤0.01% |
7,880
-399
| -5% | -$12K |
|
1070
Cerus
CERS
$566M
| $250K | ﹤0.01% |
84,222
-8,010
| -9% | -$24.1K |
|
|
EXPR
1071
DELISTED
Express, Inc.
EXPR
| $250K | ﹤0.01% |
15,833
+4,847
| +44% | +$97.9K |
|
1072
Madrigal Pharmaceuticals
MDGL
$12.2B
| $249K | ﹤0.01% |
+1,029
| New | +$280K |
|
1073
Lifetime Brands
LCUT
$221M
| $248K | ﹤0.01% |
42,237
+15,181
| +56% | +$108K |
|
1074
Doximity
DOCS
$4.49B
| $248K | ﹤0.01% |
7,648
-358,099
| -98% | -$11.9M |
|
1075
Adtran
ADTN
$663M
| $247K | ﹤0.01% |
15,603
-52,642
| -77% | -$913K |
|
Similar funds
FDCDDQ
TWC
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.